Clinical trials in T-cell lymphoma

The table below shows a list of The Lymphoma Group's current clinical trials open for recruitment for T-Cell lymphoma patients.

Please note: The link for more information on the trials below is currently not operating. Apologies for this inconvenience while we try to fix the problem. In the meantime please get in touch via our email lymphomaclinicaltrials@christie.nhs.uk and we can provide you with more information on the trial.

 

 

Trial Name

 

Description

 

Click the link for more information (external page)

 

AVAIL-T

 

A Phase 2a trial of Avelumab, an anti-PD-L1 antibody to treat peripheral T-cell lymphoma (PTCL)

Suitable for patients with lymphoma which has come back after previous treatment

 

 

 

ADCT-301

 

A phase 1 study testing a new drug, ADCT-301

Suitable for patients with lymphoma which has come back after previous treatment

 

 

 

C25006

 

Phase 4 study of Brentuximab vedotin, a CD30-targeting antibody-drug conjugate

Suitable for patients with lymphoma which has come back after previous treatment

 

 

 

RESMAIN

 

Phase 2 study testing resminostat as treatment for people with mycosis fungoides (MF) or Sézary syndrome (SS), a type of cutaneous (skin) T-cell lymphoma.

Suitable for patients who have received treatment and their lymphoma is stable or in remission

 

 

 

ROMI-CAR

 

Phase 1-2 study looking at the dosage and effectiveness of new drugs romidepsin and carfilzomib

Suitable for patients with lymphoma which has come back after previous treatment

 

 

 

PROCLIPI

 

A non-medicinal (observational) clinical trial involving collecting data on patients with mycosis fungoides (primary cutaneous T cell lymphoma) and Sézary syndrome (SS), to help determine how we manage future patients.

 

 

 

*Please note, we update this page fortnightly

With special thanks to the following: